Jiaying Lin

ORCID: 0000-0002-1473-5636 · 17 papers in corpus
observational 2025
Journal of ovarian research ·doi:10.1186/s13048-025-01885-y

BACKGROUND: In assisted reproductive technology, preventing premature ovulation is crucial for achieving successful pregnancy outcomes. The traditional GnRH antagonist protocol is commonly used to suppress the luteinizing hormone (LH) surge…

observational 2025
Drug design, development and therapy ·doi:10.2147/dddt.s523076

PURPOSE: To investigate possible differences in cumulative live birth rates (CLBRs) among three progestins medroxyprogesterone acetate (MPA), dydrogesterone (DYG), and Progesterone within the progestin-primed ovarian stimulation (PPOS) prot…

2024
·doi:10.1016/j.apmt.2024.102409
observational 2023
International Immunopharmacology ·doi:10.1016/j.intimp.2022.109552

OBJECTIVE: To investigate the effect of inactivated coronavirus disease 2019 (COVID-19) vaccination on frozen-thawed embryo transfer (FET) outcomes. METHODS: This retrospective cohort study enrolled 1,210 patients undergoing FET cycles in …

observational 2023
Frontiers in endocrinology ·doi:10.3389/fendo.2023.1188433

BACKGROUND: ICSI (intracytoplasmic sperm injection) leads to a reduced male-to-female ratio at birth, whereas blastocyst transfer results in an increased male-to-female ratio. However, limited knowledge exists regarding the impact of these …

observational 2022
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-022-00957-8

BACKGROUND: To explore the effect of pre-pregnancy body mass index (BMI) on neonatal outcomes among singletons born after frozen embryo transfer (FET). METHODS: This large retrospective cohort study included 18,683 singleton infants born a…

observational 2022
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-022-00896-4

OBJECTIVE: The present study aimed to evaluate pregnancy and neonatal outcomes in women, with a previous history of wedge resection for interstitial pregnancy, in frozen-thawed embryo transfer (FET) cycles of IVF/ICSI. METHODS: The present…

observational 2022
Biological research ·doi:10.1186/s40659-022-00395-1

BACKGROUND: Unsubstantiated concerns have been raised on the potential correlation between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination and infertility, leading to vaccine hesitancy in reproductive-aged populatio…

observational 2022
Journal of inflammation research ·doi:10.2147/jir.s347729

PURPOSE: To investigate the impact of inactivated SARS-CoV-2 vaccination on in vitro fertilization (IVF) outcomes. PATIENTS AND METHODS: This retrospective cohort study included 2185 patients undergoing fresh IVF cycles from June 1st to Se…

observational 2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.766601

PURPOSE: To evaluate the association of endometrial thickness (EMT) with obstetric and neonatal outcomes in women with polycystic ovary syndrome (PCOS). METHODS: A total of 1755 subfertile PCOS women with singleton livebirths after frozen-…

observational 2020
Reproductive biology and endocrinology : RB&E ·doi:10.1186/s12958-020-00597-w

BACKGROUND: Decreased endometrial thickness (EMT) has been suggested to be associated with reduced birthweight of in vitro fertilization/intracytoplasmic sperm injection (IVF/ICSI) newborns. Considering the differences in ovarian stimulatio…

observational 2020
Annals of translational medicine ·doi:10.21037/atm-20-1459

BACKGROUND: Peak endometrial thickness (EMT), measured on the end of follicular phase or early luteal phase, is the most widely used marker for endometrial receptivity during infertility treatment. However, the clinical significance of foll…

other 2019
Frontiers in endocrinology ·doi:10.3389/fendo.2019.00325

Background: The ability of anti-Müllerian hormone (AMH) to predict ovarian response has been studied extensively in gonadotropin-releasing hormone agonist and antagonist treatments, but no information is available regarding its value in pro…

observational 2019
Drug design, development and therapy ·doi:10.2147/dddt.s210228

PURPOSE: Dydrogesterone (DYG) has been demonstrated to be an alternative progestin in the progestin-primed ovarian stimulation (PPOS) protocol with comparable oocyte retrieval and pregnancy outcomes. However, its safety regarding neonatal o…

observational 2019
Drug design, development and therapy ·doi:10.2147/dddt.s212235

OBJECTIVE: Frozen-thawed embryo transfer enables surplus embryos derived from IVF or IVF-ICSI treatment to be stored and transferred in subsequent cycles into a more "physiologic environment". This study aimed to investigate the clinical ef…

observational 2019
Drug design, development and therapy ·doi:10.2147/dddt.s230129

PURPOSE: Dydrogesterone (DYG) is an alternative progestin in progestin-primed ovarian stimulation (PPOS) protocol with weaker pituitary suppression than medroxyprogesterone acetate (MPA) in normal ovulatory women. However, the endocrinologi…

observational 2019
Annals of translational medicine ·doi:10.21037/atm.2019.11.74

BACKGROUND: Non-elective freeze-all policy has been increasingly utilized in assisted reproductive treatment, but the optimal timing of frozen-thawed embryo transfer (FET) after controlled ovarian stimulation (COS) remains to be investigate…